Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,610 | 2,770 | 06.06. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.04. | Nightingale Health Oyj: Nightingale Health's laboratory implementation in the United States progresses as planned - opens first to medical research customers in Summer 2025 | 98 | GlobeNewswire (Europe) | Nightingale Health Plc | Press Release | April 10, 2025 at 09:30:00 EEST
Nightingale Health Plc
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF) a pioneer in disease risk detection... ► Artikel lesen | |
25.03. | Citi Appointed as Depositary Bank for Nightingale Health OYJ's ADR Program | 306 | Business Wire | Citi Issuer Services, acting through Citibank N.A., has been appointed by Nightingale Health OYJ ("Nightingale Health") to act as depositary bank for its sponsored Level 1 American Depositary Receipt... ► Artikel lesen | |
21.03. | Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US | 1 | Cision News | ||
21.03. | OTC Markets Group Welcomes NIGHTINGALE HEALTH OYJ to OTCQX | 1 | GlobeNewswire (USA) | ||
19.03. | Nasdaq Helsinki welcomes Nightingale Health to Main Market | 153 | GlobeNewswire | 19 March 2025, Helsinki - Nasdaq (Nasdaq: NDAQ) announces that trading in Nightingale Health Plc shares (ticker: HEALTH) will commence today on the Main Market of Nasdaq Helsinki. Nightingale Health... ► Artikel lesen | |
18.03. | Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025 | 1 | Cision News | ||
18.03. | Nightingale Health Plc: Move From Nasdaq First North Growth Market Finland To The Official List | 150 | GlobeNewswire | EXCHANGE NOTICE, 18 MARCH 2025 SHARES
NIGHTINGALE HEALTH PLC: MOVE FROM NASDAQ FIRST NORTH GROWTH MARKET FINLAND TO THE OFFICIAL LIST
At the request of Nightingale Health Plc, the... ► Artikel lesen | |
NIGHTINGALE HEALTH Aktie jetzt für 0€ handeln | |||||
17.03. | The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus | 1 | Cision News | ||
17.03. | Nightingale Health Oyj: Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the ... | 124 | GlobeNewswire (Europe) | Nightingale Health Plc
Stock exchange release
17 March 2025 at 1:55 p.m. (EET)Nightingale Health Plc ("Nightingale Health" or the "Company") announced on 27 November 2024 that it was investigating... ► Artikel lesen | |
12.03. | Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki | 3 | Cision News | ||
06.03. | Nightingale Health Oyj: Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States | 318 | GlobeNewswire (Europe) | Nightingale Health Group's Half-year report 1 July 2024 - 31 December 2024 (unaudited) Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States
Company... ► Artikel lesen | |
28.02. | Nightingale Health to publish half-year report for July - December 2024 on 6 March 2025 | 1 | Cision News | ||
27.02. | Nightingale Health announces the development of innovative LLM based tool to empower anyone to take informed decisions to lower disease risks | 2 | Cision News | ||
07.02. | Nightingale Health Oyj: Nightingale Health announces its updated regulatory plan in the United States | 171 | GlobeNewswire (Europe) | Nightingale Health Plc
Press release
7 February 2025 at 2:15 p.m. (EET)Nightingale Health Plc ("Nightingale Health"), a pioneer in disease risk detection and preventative health announces its regulatory... ► Artikel lesen | |
27.01. | Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region | 1 | Cision News | ||
23.01. | Nightingale Health announces the performance metrics of its latest generation disease risk assessments to be rolled out in Singapore and the United States | 1 | Cision News | ||
23.12.24 | Conversion of Nightingale Health Plc's EMP shares to Series B shares | 1 | Cision News | ||
20.12.24 | Nightingale Health Plc - Managers' Transactions - Olli Karhi | 1 | Cision News | ||
18.12.24 | Nightingale Health Plc appoints Lago Kapital as liquidity provider | 2 | Cision News | ||
13.12.24 | Nightingale Health Plc: Subscription of Series B shares with option rights | 2 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INTUITIVE SURGICAL | 488,00 | -0,15 % | What Makes Intuitive Surgical (ISRG) an Investment Bet? | ||
RHOEN-KLINIKUM | 13,000 | +1,56 % | Dividendenbekanntmachungen (04.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADESSO SE DE000A0Z23Q5 - 0,75 EUR AGEAS SA/NV BE0974264930 - 2 EUR AIR LEASE CORPORATION US00912X3026 0,22 USD 0,1934 EUR ANALOG... ► Artikel lesen | |
BICO GROUP | 3,360 | +0,12 % | Toni Haberthür, CEO Bico / Hilding Anders Switzerland, im Interview | von Patrick Gunti Moneycab.com: Herr Haberthür, Bico steht «für ä tüüfä gsundä Schlaaf» und ist seit Jahrzehnten die bekannteste Marke der Schweiz im Bereich hochwertiger Schlaflösungen. Wie prägt die... ► Artikel lesen | |
M1 KLINIKEN | 16,220 | +2,79 % | M1 Kliniken: Kann der Schönheitstrend die Aktie noch schöner machen? | Mit einem EBIT-Wachstum von 29 Prozent startet M1 Kliniken (DE000A0STSQ8) fulminant ins Jahr 2025. Das Ergebnis je Aktie von 0,31 Euro kann sich sehen lassen. Doch wie nachhaltig ist der Erfolg in der... ► Artikel lesen | |
BAXTER | 26,465 | -0,28 % | Former Baxter kidney unit Vantive to invest $1B in digitally enabled therapies | ||
LIFEWARD | 1,200 | +0,84 % | Lifeward Ltd.: Finanzvorstand Michael Lawless kündigt Rücktritt an | ||
JD HEALTH | 4,500 | +2,27 % | Aktie von JD Health läuft heute schlechter (4,36 €) | Das Wertpapier von JD Health notiert am Donnerstag leichter. Der jüngste Kurs betrug 4,36 Euro. Ein Minus von 2,68 Prozent steht gegenwärtig für der Anteilsschein von JD Health zu Buche. Die Aktie verbilligte... ► Artikel lesen | |
COOPER COMPANIES | 64,00 | +0,79 % | Cooper Companies-Aktie mit leichten Kursgewinnen (61,4384 €) | Im US-amerikanischen Wertpapierhandel notiert das Wertpapier von Cooper Companies gegenwärtig ein wenig fester. Das Papier kostete zuletzt 70,35 US-Dollar. Für die Aktie von Cooper Companies steht gegenwärtig... ► Artikel lesen | |
COMMUNITY HEALTH SYSTEMS | 3,280 | -0,61 % | COMMUNITY HEALTH SYSTEMS INC - 8-K, Current Report | ||
ONWARD MEDICAL | 4,305 | +0,82 % | ONWARD Medical NV: ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants | Groundbreaking procedures extend ONWARD's leadership in the rapidly emerging brain-computer interface (BCI) fieldARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury... ► Artikel lesen | |
RAMSAY HEALTH CARE | 21,400 | 0,00 % | C-Rad AB: C-RAD expands footprint in France, by joining forces with leading private healthcare provider Ramsay Santé with high-precision SGRT systems to a total value of 8.5 MSEK | C-RAD has signed a strategic agreement with Ramsay Santé, one of Europe's leading private healthcare providers, for the delivery and installation of its advanced Surface Guided Radiation Therapy (SGRT)... ► Artikel lesen | |
SENSUS HEALTHCARE | 4,340 | 0,00 % | Sensus Healthcare, Inc. - 8-K, Current Report | ||
SONIDA SENIOR LIVING | 22,000 | +3,77 % | Sonida Senior Living outlines $100M NOI target amid portfolio repositioning and strategic acquisitions | ||
SAVARIA | 12,300 | 0,00 % | Dividendenbekanntmachungen (30.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,34 USD 0,299 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1583 EUR AEW UK REIT PLC GB00BWD24154 0... ► Artikel lesen | |
XVIVO PERFUSION | 28,720 | +0,77 % | XVIVO Perfusion AB: XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston | GOTHENBURG, SE / ACCESS Newswire / April 29, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The 12-month follow-up results from XVIVO's European multicenter heart trial, NIHP2019, was presented... ► Artikel lesen |